Papadatos-Pastos, D; Yuan, W; Pal, A; Crespo, M; Ferreira, A; Gurel, B; Prout, T; ... Minchom, A; + view all Papadatos-Pastos, D; Yuan, W; Pal, A; Crespo, M; Ferreira, A; Gurel, B; Prout, T; Ameratunga, M; Chénard-Poirier, M; Curcean, A; Bertan, C; Baker, C; Miranda, S; Masrour, N; Chen, W; Pereira, R; Figueiredo, I; Morilla, R; Jenkins, B; Zachariou, A; Riisnaes, R; Parmar, M; Turner, A; Carreira, S; Yap, C; Brown, R; Tunariu, N; Banerji, U; Lopez, J; De Bono, J; Minchom, A; - view fewer (2022) Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors. Journal for ImmunoTherapy of Cancer , 10 (6) , Article e004495. 10.1136/jitc-2022-004495.